Anti-SCGB3A2 antibody [EPR11463]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal SCGB3A2 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 14 publications.
View Alternative Names
PNSP1, UGRP1, UNQ566/PRO1128, SCGB3A2, Secretoglobin family 3A member 2, Pneumo secretory protein 1, Uteroglobin-related protein 1, PnSP-1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-SCGB3A2 antibody [EPR11463] (AB181853)
Immunocytochemistry/Immunofluorescence analysis of A549 (human lung carcinoma) labelling SCGB3A2 with purified ab181853 at 1/500. Cells were fixed with 100% methanol. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody (ab150077). Nuclei counterstained with DAPI (blue).
Control : PBS only
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SCGB3A2 antibody [EPR11463] (AB181853)
Immunofluorescent analysis of A549 cells (paraformaldehyde-fixed, 4%) labeling SCGB3A2 with ab181853 at 1/500 dilution followed by Goat anti rabbit IgG Alexa Fluor 555) secondary at 1/200 dilution and counter-stained with DAPI.
- WB
Supplier Data
Western blot - Anti-SCGB3A2 antibody [EPR11463] (AB181853)
All lanes:
Western blot - Anti-SCGB3A2 antibody [EPR11463] (ab181853) at 1/1000 dilution
All lanes:
Human SCGB3A2 recombinant protein at 0.01 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L) HRP at 1/1000 dilution
Predicted band size: 10 kDa
false
- WB
Supplier Data
Western blot - Anti-SCGB3A2 antibody [EPR11463] (AB181853)
All lanes:
Western blot - Anti-SCGB3A2 antibody [EPR11463] (ab181853) at 1/1000 dilution
All lanes:
Calu 3 cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L) HRP at 1/1000 dilution
Predicted band size: 10 kDa
false
Related conjugates and formulations (3)
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-SCGB3A2 antibody [EPR11463]
-
Anti-SCGB3A2 antibody [EPR11463] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-SCGB3A2 antibody [EPR11463]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SCGB3A2 acts as an anti-inflammatory agent that modulates immune cell activity and cytokine signaling within the lungs. It does not form known protein complexes but interacts with other immune mediators to reduce inflammation. Furthermore SCGB3A2 has roles in cell proliferation and repair mechanisms especially in response to lung injury. Its interaction with various cytokines supports tissue regeneration and homeostasis making it important in maintaining lung function.
Pathways
SCGB3A2 interacts in immune regulatory pathways significant in lung tissue. Notably it participates in pathways related to the suppression of inflammatory cytokine production and has a working relationship with proteins such as IL-10 and TGF-beta that mitigate excessive immune reactions. These interactions exhibit roles in the regulation of immune responses and the promotion of tissue repair making SCGB3A2 part of important biological processes that protect lung integrity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Biomedicines 13: PubMed40722696
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 31:231 PubMed40495135
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 13: PubMed40299508
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical genetics 63:5394-5414 PubMed39656403
2024
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 14:6185-6201 PubMed39431015
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37887346
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37047264
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell 185:4841-4860.e25 PubMed36493756
2022
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 57:1598-1614.e8 PubMed35679862
2022
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 12:e850 PubMed35652821
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com